| Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas Q Deng, G Han, N Puebla-Osorio, MCJ Ma, P Strati, B Chasen, E Dai, ... Nature medicine 26 (12), 1878-1887, 2020 | 470 | 2020 |
| Dynamic incorporation of multiple in silico functional annotations empowers rare variant association analysis of large whole-genome sequencing studies at scale X Li, Z Li, H Zhou, SM Gaynor, Y Liu, H Chen, R Sun, R Dey, DK Arnett, ... Nature genetics 52 (9), 969-983, 2020 | 206 | 2020 |
| Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial AO Kaseb, E Hasanov, HST Cao, L Xiao, JN Vauthey, SS Lee, BG Yavuz, ... The Lancet Gastroenterology & Hepatology 7 (3), 208-218, 2022 | 188 | 2022 |
| Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma P Strati, S Ahmed, F Furqan, LE Fayad, HJ Lee, SP Iyer, R Nair, ... Blood, The Journal of the American Society of Hematology 137 (23), 3272-3276, 2021 | 168 | 2021 |
| 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy G Han, G Yang, D Hao, Y Lu, K Thein, BS Simpson, J Chen, R Sun, ... Nature communications 12 (1), 5606, 2021 | 145 | 2021 |
| Survival improvement for patients with metastatic colorectal cancer over twenty years FA Zeineddine, MA Zeineddine, A Yousef, Y Gu, S Chowdhury, A Dasari, ... Npj Precision Oncology 7 (1), 16, 2023 | 80 | 2023 |
| A framework for detecting noncoding rare-variant associations of large-scale whole-genome sequencing studies Z Li, X Li, H Zhou, SM Gaynor, MS Selvaraj, T Arapoglou, C Quick, Y Liu, ... Nature methods 19 (12), 1599-1611, 2022 | 72 | 2022 |
| Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer J Byun, Y Han, Y Li, J Xia, E Long, J Choi, X Xiao, M Zhu, W Zhou, R Sun, ... Nature genetics 54 (8), 1167-1177, 2022 | 68 | 2022 |
| Powerful gene set analysis in GWAS with the Generalized Berk-Jones statistic R Sun, S Hui, GD Bader, X Lin, P Kraft PLoS genetics 15 (3), e1007530, 2019 | 53 | 2019 |
| Smart start: rituximab, lenalidomide, and ibrutinib in patients with newly diagnosed large B-cell lymphoma J Westin, RE Davis, L Feng, F Hagemeister, R Steiner, HJ Lee, L Fayad, ... Journal of Clinical Oncology 41 (4), 745-755, 2023 | 46 | 2023 |
| Immune phenotype and response to neoadjuvant therapy in triple-negative breast cancer C Yam, EY Yen, JT Chang, RL Bassett Jr, G Alatrash, H Garber, L Huo, ... Clinical Cancer Research 27 (19), 5365-5375, 2021 | 46 | 2021 |
| Genetic variant set-based tests using the generalized berk–jones statistic with application to a genome-wide association study of breast cancer R Sun, X Lin Journal of the American Statistical Association 115 (531), 1079-1091, 2020 | 44 | 2020 |
| Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma HJJ Cherng, R Sun, B Sugg, R Irwin, H Yang, CC Le, Q Deng, L Fayad, ... Blood, The Journal of the American Society of Hematology 140 (5), 504-515, 2022 | 40 | 2022 |
| Powerful, scalable and resource-efficient meta-analysis of rare variant associations in large whole genome sequencing studies X Li, C Quick, H Zhou, SM Gaynor, Y Liu, H Chen, MS Selvaraj, R Sun, ... Nature genetics 55 (1), 154-164, 2023 | 38 | 2023 |
| Resistance mechanisms to anti–epidermal growth factor receptor therapy in RAS/RAF wild-type colorectal cancer vary by regimen and line of therapy CM Parseghian, R Sun, M Woods, S Napolitano, HM Lee, J Alshenaifi, ... Journal of Clinical Oncology 41 (3), 460-471, 2023 | 37 | 2023 |
| Acquired genomic alterations on first-line chemotherapy with cetuximab in advanced colorectal cancer: Circulating tumor DNA analysis of the CALGB/SWOG-80405 trial (Alliance) K Raghav, FS Ou, AP Venook, F Innocenti, R Sun, HJ Lenz, S Kopetz Journal of Clinical Oncology 41 (3), 472-478, 2023 | 31 | 2023 |
| Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia P Grover, O Veilleux, L Tian, R Sun, M Previtera, E Curran, L Muffly Blood Advances 6 (5), 1608-1618, 2022 | 30 | 2022 |
| Natural history and prognostic factors for localised small bowel adenocarcinoma A Colina, H Hwang, H Wang, MHG Katz, R Sun, JE Lee, J Thomas, ... ESMO open 5 (6), e000960, 2020 | 27 | 2020 |
| Genome-wide gene by lead exposure interaction analysis identifies UNC5D as a candidate gene for neurodevelopment Z Wang, B Claus Henn, C Wang, Y Wei, L Su, R Sun, H Chen, PJ Wagner, ... Environmental Health 16, 1-16, 2017 | 25 | 2017 |
| A phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer C Yam, GM Rauch, T Rahman, M Karuturi, E Ravenberg, J White, ... Investigational New Drugs 39, 509-515, 2021 | 24 | 2021 |
